XML 78 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Reporting
 6 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting

Prior to the Sheridan acquisition, the Company operated its centers as individual components of one operating and reportable segment. Upon completion of the Sheridan acquisition, the Company operates in two major lines of business - the operation of ambulatory surgery centers and providing multi-specialty outsourced physician services, which have been identified as its operating and reportable segments. Through the ambulatory services segment, the Company acquires, develops and operates ambulatory surgery centers in partnership with physicians. Through the physician services segment, the Company provides outsourced physician services in multiple specialties to hospitals, ambulatory surgery centers and other healthcare facilities, primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. The Company’s financial information by operating segment is prepared on an internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the performance of the operating segments. The Company’s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company’s chief operating decision maker which is its Chief Executive Officer. The following table presents financial information for each reportable segment (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
Net Revenue:
 
 
 
 
 
 
 
Ambulatory Services
$
310,991

 
$
278,227

 
$
594,901

 
$
537,788

Physician Services
330,959

 
—

 
617,494

 
—

Total
$
641,950

 
$
278,227

 
$
1,212,395

 
$
537,788

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
 
 
 
Ambulatory Services
$
60,304

 
$
51,616

 
$
107,612

 
$
97,622

Physician Services
67,668

 
—

 
114,115

 
—

Total
$
127,972

 
$
51,616

 
$
221,727

 
$
97,622

 
 
 
 
 
 
 
 
Adjusted EBITDA:
$
127,972

 
$
51,616

 
$
221,727

 
$
97,622

Earnings from continuing operations attributable to noncontrolling interests
57,072

 
48,918

 
104,789

 
91,572

Interest expense, net
(30,182
)
 
(6,892
)
 
(60,429
)
 
(13,852
)
Depreciation and amortization
(23,612
)
 
(8,436
)
 
(46,430
)
 
(16,695
)
Share-based compensation
(3,883
)
 
(2,506
)
 
(7,592
)
 
(4,964
)
Net change in fair value of contingent consideration
(6,410
)
 
—

 
(6,410
)
 
—

Transaction costs
(1,982
)
 
(3,579
)
 
(3,453
)
 
(3,579
)
Gain (loss) on deconsolidation
(3,035
)
 
1,366

 
(3,258
)
 
3,411

Earnings from continuing operations before income taxes
$
115,940

 
$
80,487

 
$
198,944

 
$
153,515

 
 
 
 
 
 
 
 
Acquisition and Capital Expenditures:
 
 
 
 
 
 
 
Ambulatory Services
$
64,514

 
$
28,436

 
$
118,610

 
$
40,512

Physician Services
22,822

 
—

 
110,087

 
—

Total
$
87,336

 
$
28,436

 
$
228,697

 
$
40,512